Expression of p63 and CK5/6 in early-stage lung squamous cell ... | CK7 positive CK20 negative colon cancer

NCBISkiptomaincontentSkiptonavigationResourcesHowToAboutNCBIAccesskeysMyNCBISignintoNCBISignOutJournalListThoracCancerv.6(3);2015MayPMC4448377ThoracCancer.2015May;6(3):288–295.Publishedonline2015Apr24.doi: 10.1111/1759-7714.12181PMCID:PMC4448377PMID:26273374Expressionofp63andCK5/6inearly-stagelungsquamouscellcarcinomaisnotonlyanearlydiagnosticindicatorbutalsocorrelateswithagoodprognosisYunfanMa,1MengyingFan,1LiangDai,1XiaozhengKang,1YiqiangLiu,2YuSun,2HongchaoXiong,1ZhenLiang,1WanpuYan,1andKenengChen1YunfanMa1KeyLaboratoryofCarcinogenesisandTranslationalResearch(MinistryofEducation),TheFirstDepartmentofThoracicSurgery,PekingUniversityCancerHospital&Institute,Beijing,ChinaFindarticlesbyYunfanMaMengyingFan1KeyLaboratoryofCarcinogenesisandTranslationalResearch(MinistryofEducation),TheFirstDepartmentofThoracicSurgery,PekingUniversityCancerHospital&Institute,Beijing,ChinaFindarticlesbyMengyingFanLiangDai1KeyLaboratoryofCarcinogenesisandTranslationalResearch(MinistryofEducation),TheFirstDepartmentofThoracicSurgery,PekingUniversityCancerHospital&Institute,Beijing,ChinaFindarticlesbyLiangDaiXiaozhengKang1KeyLaboratoryofCarcinogenesisandTranslationalResearch(MinistryofEducation),TheFirstDepartmentofThoracicSurgery,PekingUniversityCancerHospital&Institute,Beijing,ChinaFindarticlesbyXiaozhengKangYiqiangLiu2DepartmentofPathology,PekingUniversityCancerHospital&Institute,Beijing,ChinaFindarticlesbyYiqiangLiuYuSun2DepartmentofPathology,PekingUniversityCancerHospital&Institute,Beijing,ChinaFindarticlesbyYuSunHongchaoXiong1KeyLaboratoryofCarcinogenesisandTranslationalResearch(MinistryofEducation),TheFirstDepartmentofThoracicSurgery,PekingUniversityCancerHospital&Institute,Beijing,ChinaFindarticlesbyHongchaoXiongZhenLiang1KeyLaboratoryofCarcinogenesisandTranslationalResearch(MinistryofEducation),TheFirstDepartmentofThoracicSurgery,PekingUniversityCancerHospital&Institute,Beijing,ChinaFindarticlesbyZhenLiangWanpuYan1KeyLaboratoryofCarcinogenesisandTranslationalResearch(MinistryofEduca

常見健康問答

延伸文章資訊
Colorectal Carcinoma | CK7 positive CK20 negative colon cancer
IMMUNOHISTOCHEMISTRY. Metastatic colorectal adenocarcinomas are most commonly diffusely and strongly positive for CK20 and negative for CK7 (Figures ...
Aberrant cytokeratin expression as a possible prognostic ... | CK7 positive CK20 negative colon cancer
colorectal carcinoma (CRC), although CK7+ or CK20− phenotypes are ... SRCCs were negative for CK7 and strongly positive for CK20.
CK7 expression associates with the location, differentiation ... | CK7 positive CK20 negative colon cancer
Keywords: cytokeratin 7, colorectal cancer, polyploidy giant cancer cells, ... Most CRCs show positive IHC staining for CK20 and negative staining for CK7. ... For the CK7 negative group, no tumor cells yielded positive IHC ...
CK7, CK20, CDX2 and MUC2 Immunohistochemical Staining ... | CK7 positive CK20 negative colon cancer
Colorectal adenocarcinoma, the most common tumor that ... CK7-negative, CK20 diffuse positive, CDX2-positive, CEA diffuse positive, ...
Immunohistochemical staining of cytokeratin 20 and ... | CK7 positive CK20 negative colon cancer
Worldwide, colorectal carcinoma (CRC) is associated with significant mortality ... strong CK7 expression and conversely negative CK20 immunoexpression. ... Cells were considered positive for CK20 and CK7 when distinct ...
Cytokeratin 7 and Cytokeratin 20 expression in colorectal ... | CK7 positive CK20 negative colon cancer
The CK7 and CK20 expression patterns were different in colorectal ... cell carcinoma most frequently exhibited a K7-negative and K20-positive ...
Expression of Cytokeratin 20 Indicates Invasive Histological ... | CK7 positive CK20 negative colon cancer
Coordinate CK7/CK20 expression profiles have been extensively studied in a ... The CK7−/CK20+ profile is known to be highly characteristic of colorectal cancer ... 156 PDAs, 50 (32.1%) were positive and 106 (67.9%) were negative for CK7, ...
Differential diagnostic and functional role of the multi-marker ... | CK7 positive CK20 negative colon cancer
According to several studies the multi-marker phenotype CK20+/CK7− is observed in colorectal cancer in approximately 75–95%2, 14 of cases whereas the multi-marker phenotype CK20−/CK7+ favors primary tumors of the lung, breast, biliary tract, pancreas, ovary and endometrium.
The value of CDX2 and cytokeratins 7 and 20 expression in ... | CK7 positive CK20 negative colon cancer
However, CDX2 expression was also found in gastric carcinoma, and ... For negative control samples, the primary antibody was omitted for each run. ... Among the CK7-/CK20- colorectal tumors CDX2 was positive in 16 of 17 ...
Expression of p63 and CK5/6 in early-stage lung squamous cell ... | CK7 positive CK20 negative colon cancer
Colon-Invasive carcinoma | CK7 positive CK20 negative colon cancer
Keratin 7 | CK7 positive CK20 negative colon cancer
Cancer of Unknown Primary Sites: What Radiologists Need to Know ... | CK7 positive CK20 negative colon cancer
Cytokeratin 7-positive/cytokeratin 20-negative cecal ... | CK7 positive CK20 negative colon cancer
Bayrak et al. reported that a CK7-positive/CK20-negative expression pattern was observed in only 1.7 % (2 of 118) of colorectal carcinomas [10].